Publications

Jensen IS, Wu C, Fan W, Lodise T, Nicolau, DP, DuFour S, Cyr PL, et al. 2016. Use of oritivancin in moderate-severe ABSSSI patients requiring IV antibiotics: US hospital budget impact analysis. J Manag Care Spec Pharm 22(6):752-64; doi: 10.18553/jmcp.2016.22.6.752. PMID: 27231802.

Jensen IS, Lodise TP, Fan W, Wu C, Cyr PL, Nicolau DP, DuFour S, et al. 2016. Use of oritavancin in acute bacterial skin and skin structure infection patients receiving intravenous antibiotics: A US hospital budget impact analysis. Clin Drug Investig. 2016 36(2):157-68; doi: 10.1007/s40261-015-0365-8. PMID: 26692006.

Wu E, Jensen IS, Cyr PL, Fan W, Mitchell M, Sulham K, Nathwani D. Use of oritavancin for the treatment of skin and soft tissue infections: A UK hospital budget impact analysis. ISPOR 20th Annual International Meeting, Philadelphia, PA, 2015.

Jensen I, Halbert R, Giuseppe R, Naoshy S, Iqbal SU, Zhimin X, McSweeney P. 2015. A hospital budget impact model to evaluate plerixafor in stem cell mobilization: Impact of primary research and direct stakeholder engagement. Eur J Hosp Pharm 22(3):142–149; doi: 10.1136/ejhpharm-2014-000543.

Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL, Jensen IS. A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10, ISPOR 17th Annual European Congress 2014.

Jensen IS, Bay C, Cyr PL. Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18^th Annual International Meeting, New Montreal Quebec, 2014.

Jensen IS, Wu C, Bay CB, Cyr PL. Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.

Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL, Jensen IS. A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16^th Annual European Congress, Amsterdam, Netherlands, 2014.

Bay C, Cyr PL, Jensen IS. Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.

Jensen IS, Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin’s lymphoma in the United States: A budgetary impact analysis. Abstract C14, Academy of Managed Care Pharmacy 26^th Annual Meeting & Expo, 2014.

Jensen IS, Halbert RJ, Grosvenor A, Swartz E, Rossi G, Naoshy S, et al. Incorporating stakeholder input into budget impact models to compare stem cell mobilization strategies. Abstract PCN43, ISPOR 18th Annual International Meeting, 2013.

Cyr P, Sidhu M, Hussain R, Hromin T, Jensen I, Kuan R. Dual-acting osmotic and stimulant laxative for bowel cleansing in an elderly population: A US payer budget impact analysis. Abstract PCN22, ISPOR 18th Annual International Meeting, 2013.

Jensen I, Ogborne R, Cyr P. A German hospital budget impact model comparing antibiotic therapies in complicated skin and skin structure infections and bacteremia. ISPOR 17th Annual International Meeting, 2012.

Jensen I, Helm T, Cyr P. Impact of complications in solid organ transplants on hospital charges and length of stay. Abstract PSU15, ISPOR 17th Annual International Meeting, 2012.

Jensen I, Helm T, Cyr P. Impact of dysphagia on U.S. hospital charges in patients with comorbid conditions. Abstract PGI9, ISPOR 14th Annual European Congress, 2011.

Jensen I, Helm T, Cyr P. Impact of complications from dysphagia on hospital charges in the United States. Abstract PGI7, ISPOR 14th Annual European Congress, 2011.

McNamara JF, Lombardo H, Pillai SK, Jensen I, Albericio F, Kates SK. 2000. An efficient solid-phase strategy for the construction of chemokines. J Pept Sci 6(10):512–518; doi: 10.1002/1099-1387(200010)6:10<512::AID-PSC269>3.0.CO;2-A. PMID: 11071265.

Casale RA, Jensen IS, Egholm M. 1999. Synthesis of PNA oligomers by Fmoc chemistry. In Peptide Nucleic Acids: Protocols & Applications. Weymondham, UK: Horizon Scientific Press.

McNamara JF, Lombardo H, Pillai SK, Jensen IS, Kates SA. A comparison of solid-phase techniques for the construction of chemokines. In Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.

Segal BM, McNamara JF, Jensen IS, Kates SA, Holm RH. Design and synthesis of cyclic peptides for iron-sulfur cluster assembly and encapsulation. In: Bajusz S, Hudecz F (eds), Peptides 1998: Proceedings of the Twenty-Fifth European Peptide Symposium 30 August–4 September 1998, Budapest. Mayflower Worldwide Limited, Birmingham, England, 1999.